A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Clinical trial NCT00224120 · COMPLETED

Trial details

NCT number: NCT00224120
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2005-05-01
Primary completion: 2006-05-01
Enrollment: 462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.